FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jennifer Crossley

Research Profile

Physiology

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Prenatal Diagnosis

Anatomy

Phenomena

False Positive Reactions

Geographic Areas

Scotland

Co-author Network

Publications

TOP 3
Gordon C S Smith; Jennifer A Crossley; David A Aitken; Nicola Jenkins; Fiona Lyall; Alan D Cameron; J Michael Connor; Richard Dobbie
Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth.
Gordon C S Smith; Imran Shah; Ian R White; Jill P Pell; Jennifer A Crossley; Richard Dobbie
Maternal and biochemical predictors of antepartum stillbirth among nulliparous women in relation to gestational age of fetal death.
Gordon C S Smith; Imran Shah; Jill P Pell; Jennifer A Crossley; Richard Dobbie
Maternal obesity in early pregnancy and risk of spontaneous and elective preterm deliveries: a retrospective cohort study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jennifer Crossley (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Gordon C S Smith; Jennifer A Crossley; David A Aitken; Nicola Jenkins; Fiona Lyall; Alan D Cameron; J Michael Connor; Richard Dobbie
Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth.
Obstetrics and gynecology 2007;109(6):1316-24.
2007: Gordon C S Smith; Imran Shah; Ian R White; Jill P Pell; Jennifer A Crossley; Richard Dobbie
Maternal and biochemical predictors of antepartum stillbirth among nulliparous women in relation to gestational age of fetal death.
BJOG : an international journal of obstetrics and gynaecology 2007;114(6):705-14.
2007: Gordon C S Smith; Imran Shah; Jill P Pell; Jennifer A Crossley; Richard Dobbie
Maternal obesity in early pregnancy and risk of spontaneous and elective preterm deliveries: a retrospective cohort study.
American journal of public health 2007;97(1):157-62.
2006: Gordon C S Smith; Imran Shah; Ian R White; Jill P Pell; Jennifer A Crossley; Richard Dobbie
Maternal and biochemical predictors of spontaneous preterm birth among nulliparous women: a systematic analysis in relation to the degree of prematurity.
International journal of epidemiology 2006;35(5):1169-77.
2006: Gordon C S Smith; Imran Shah; Jennifer A Crossley; David A Aitken; Jill P Pell; Scott M Nelson; Alan D Cameron; Michael J Connor; Richard Dobbie
Pregnancy-associated plasma protein A and alpha-fetoprotein and prediction of adverse perinatal outcome.
Obstetrics and gynecology 2006;107(1):161-6.
2005: Kevin Spencer; Jennifer A Crossley; David A Aitken; Kypros H Nicolaides
Second-trimester levels of pregnancy-associated plasma protein-A and free beta-hCG in pregnancies with trisomy 13.
Prenatal diagnosis 2005;25(5):358-61.
2004: Gordon C S Smith; Jennifer A Crossley; David A Aitken; Jill P Pell; Alan D Cameron; J Michael Connor; Richard Dobbie
First-trimester placentation and the risk of antepartum stillbirth.
JAMA : the journal of the American Medical Association 2004;292(18):2249-54.
2004: Emily J Stenhouse; Jennifer A Crossley; David A Aitken; K Brogan; Alan D Cameron; J Michael Connor
First-trimester combined ultrasound and biochemical screening for Down syndrome in routine clinical practice.
Prenatal diagnosis 2004;24(10):774-80.
2004: Gordon C S Smith; Angela M Wood; Jill P Pell; Ian R White; Jennifer A Crossley; Richard Dobbie
Second-trimester maternal serum levels of alpha-fetoprotein and the subsequent risk of sudden infant death syndrome.
The New England journal of medicine 2004;351(10):978-86.
2004: Euan Wallace; Budi Marjono; David A Brown; Jennifer A Crossley; Stephen Tong; David A Aitken; Sam Breit
Maternal serum and amniotic fluid levels of macrophage inhibitory cytokine 1 in Down syndrome and chromosomally normal pregnancies.
Prenatal diagnosis 2004;24(3):224-6.
2003: Kevin Spencer; Jennifer A Crossley; David A Aitken; A B J Nix; Frank Dunstan; K Williams
The effect of temporal variation in biochemical markers of trisomy 21 across the first and second trimesters of pregnancy on the estimation of individual patient-specific risks and detection rates for Down's syndrome.
Annals of clinical biochemistry 2003;40(Pt 3):219-31.
2003: Howard Cuckle; Svetlana Arbuzova; Kevin Spencer; Jennifer A Crossley; Gad Barkai; David A Krantz; F Muller; M Nikolenko; David A Aitken; Terrence W Hallahan; James N Macri; Philip Buchanan
Frequency and clinical consequences of extremely high maternal serum PAPP-A levels.
Prenatal diagnosis 2003;23(5):385-8.
2002: Kevin Spencer; Jennifer A Crossley; David A Aitken; A B J Nix; Frank Dunstan; K Williams
Temporal changes in maternal serum biochemical markers of trisomy 21 across the first and second trimester of pregnancy.
Annals of clinical biochemistry 2002;39(Pt 6):567-76.
2002: Gordon C S Smith; Emily J Stenhouse; Jennifer A Crossley; David A Aitken; Alan D Cameron; J Michael Connor
Early-pregnancy origins of low birth weight.
Nature 2002;417(6892):916.
2002: Jennifer A Crossley; David A Aitken; Alan D Cameron; Elizabeth McBride; J Michael Connor
Combined ultrasound and biochemical screening for Down's syndrome in the first trimester: a Scottish multicentre study.
BJOG : an international journal of obstetrics and gynaecology 2002;109(6):667-76.
2002: Gordon C S Smith; Emily J Stenhouse; Jennifer A Crossley; David A Aitken; Alan D Cameron; J Michael Connor
Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth.
The Journal of clinical endocrinology and metabolism 2002;87(4):1762-7.
2002: Jennifer A Crossley; David A Aitken; S M L Waugh; T Kelly; J Michael Connor
Maternal smoking: age distribution, levels of alpha-fetoprotein and human chorionic gonadotrophin, and effect on detection of Down syndrome pregnancies in second-trimester screening.
Prenatal diagnosis 2002;22(3):247-55.
2001: Euan Wallace; Donato D'Antona; T Veveris-Lowe; Jennifer A Crossley; Ross Barnard
Growth hormone binding protein in normal and aneuploid pregnancy: a paradoxical decrease in trisomy 18.
BJOG : an international journal of obstetrics and gynaecology 2001;108(7):701-3.
2000: Kevin Spencer; E Berry; Jennifer A Crossley; David A Aitken; Kypros H Nicolaides
Is maternal serum total hCG a marker of trisomy 21 in the first trimester of pregnancy?
Prenatal diagnosis 2000;20(4):311-7.
1999: Jennifer A Crossley; D A Aitken
Deriving risks of Down's syndrome from nuchal translucency measurements.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 1999;14(6):438.
1999: K Spencer; Jennifer A Crossley; K Green; D J Worthington; K Brownbill; David A Aitken
Second trimester levels of pregnancy associated plasma protein-A in cases of trisomy 18.
Prenatal diagnosis 1999;19(12):1127-34.
1999: David A Aitken; M Ireland; E Berry; Jennifer A Crossley; JN Macri; J Burn; J Michael Connor
Second-trimester pregnancy associated plasma protein-A levels are reduced in Cornelia de Lange syndrome pregnancies.
Prenatal diagnosis 1999;19(8):706-10.
1999: J J Hsu; K Spencer; David A Aitken; Jennifer A Crossley; T Choi; M Ozaki; H Tazawa
Urinary free beta hCG, beta core fragment and total oestriol as markers of Down syndrome in the second trimester of pregnancy.
Prenatal diagnosis 1999;19(2):146-58.
1998: Euan Wallace; Jennifer A Crossley; SC Ritoe; David A Aitken; K Spencer; nigel P groome
Evolution of an inhibin A ELISA method: implications for Down's syndrome screening.
Annals of clinical biochemistry 1998;35 ( Pt 5)():656-64.
1998: T M Reynolds; F Dunstan; B Nix; K Williams; Jennifer A Crossley; S Holding; David A Krantz; Dave Wright; I Bray; Kevin Spencer
Response to: Wald, N.J., Hackshaw, A.K. (1997). Combining ultrasound and biochemistry in first-trimester screening for Down's syndrome, Prenat. Diagn., 17, 821-829.
Prenatal diagnosis 1998;18(5):511-9.
1998: Euan Wallace; Jennifer A Crossley; Simon C Riley; C Balfour; nigel P groome; David A Aitken
Inhibin-B and pro-alphaC-containing inhibins in amniotic fluid from chromosomally normal and Down syndrome pregnancies.
Prenatal diagnosis 1998;18(3):213-7.
1997: Yanick J Crow; John Tolmie; Jennifer A Crossley; David A Aitken
Maternal serum alpha-fetoprotein levels in congenital nephrosis.
Prenatal diagnosis 1997;17(11):1089.
1997: D Newby; David A Aitken; Jennifer A Crossley; AG Howatson; JN Macri; J Michael Connor
Biochemical markers of trisomy 21 and the pathophysiology of Down's syndrome pregnancies.
Prenatal diagnosis 1997;17(10):941-51.
1997: Euan Wallace; Jennifer A Crossley; SC Ritoe; nigel P groome; David A Aitken
Maternal serum inhibin-A in pregnancies complicated by insulin dependent diabetes mellitus.
British journal of obstetrics and gynaecology 1997;104(8):946-8.
1997: E Berry; David A Aitken; Jennifer A Crossley; JN Macri; J Michael Connor
Screening for Down's syndrome: changes in marker levels and detection rates between first and second trimesters.
British journal of obstetrics and gynaecology 1997;104(7):811-7.
1997: David A Aitken; Jennifer A Crossley
Neural tube defects/alpha-fetoprotein/Down's syndrome screening.
Current opinion in obstetrics & gynecology 1997;9(2):113-20.
1997: Euan Wallace; Jennifer A Crossley; nigel P groome; David A Aitken
Amniotic fluid inhibin-A in chromosomally normal and Down's syndrome pregnancies.
The Journal of endocrinology 1997;152(1):109-12.
1997: Euan Wallace; Simon C Riley; Jennifer A Crossley; SC Ritoe; A Horne; M Shade; PM Ellis; David A Aitken; nigel P groome
Dimeric inhibins in amniotic fluid, maternal serum, and fetal serum in human pregnancy.
The Journal of clinical endocrinology and metabolism 1997;82(1):218-22.
1996: D Newby; David A Aitken; Jennifer A Crossley; A G Howatson; J Michael Connor
The pathophysiology of Down's syndrome pregnancies.
Early human development 1996;47 Suppl():S67-8.
1996: David A Aitken; B S Syvertsen; Jennifer A Crossley; E Berry; J Michael Connor
Heat-stable and immunoreactive placental alkaline phosphatase in maternal serum from Down's syndrome and trisomy 18 pregnancies.
Prenatal diagnosis 1996;16(11):1051-4.
1996: Jennifer A Crossley; E Berry; David A Aitken; J Michael Connor
Insulin-dependent diabetes mellitus and prenatal screening results: current experience from a regional screening programme.
Prenatal diagnosis 1996;16(11):1039-42.
1996: David A Aitken; Euan Wallace; Jennifer A Crossley; I A Swanston; Y van Pareren; M van Maarle; nigel P groome; James N Macri; J Michael Connor
Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
The New England journal of medicine 1996;334(19):1231-6.
1995: E Berry; David A Aitken; Jennifer A Crossley; James N Macri; J Michael Connor
Analysis of maternal serum alpha-fetoprotein and free beta human chorionic gonadotrophin in the first trimester: implications for Down's syndrome screening.
Prenatal diagnosis 1995;15(6):555-65.
1994: Kevin Spencer; David A Aitken; Jennifer A Crossley; G McCaw; E Berry; R Anderson; J Michael Connor; James N Macri
First trimester biochemical screening for trisomy 21: the role of free beta hCG, alpha fetoprotein and pregnancy associated plasma protein A.
Annals of clinical biochemistry 1994;31 ( Pt 5)():447-54.
1994: Jennifer A Crossley; David A Aitken; E Berry; J Michael Connor
Impact of a regional screening programme using maternal serum alpha fetoprotein (AFP) and human chorionic gonadotrophin (hCG) on the birth incidence of Down's syndrome in the west of Scotland.
Journal of medical screening 1994;1(3):180-3.
1993: David A Aitken; G McCaw; Jennifer A Crossley; E Berry; J Michael Connor; Kevin Spencer; James N Macri
First-trimester biochemical screening for fetal chromosome abnormalities and neural tube defects.
Prenatal diagnosis 1993;13(8):681-9.
1993: Kevin Spencer; James N Macri; R W Anderson; David A Aitken; E Berry; Jennifer A Crossley; P J Wood; E J Coombes; M Stroud; D J Worthington
Dual analyte immunoassay in neural tube defect and Down's syndrome screening: results of a multicentre clinical trial.
Annals of clinical biochemistry 1993;30 ( Pt 4)():394-401.
1993: Jennifer A Crossley; David A Aitken; J Michael Connor
Second-trimester unconjugated oestriol levels in maternal serum from chromosomally abnormal pregnancies using an optimized assay.
Prenatal diagnosis 1993;13(4):271-80.
1992: G W Graham; Jennifer A Crossley; David A Aitken; J Michael Connor
Variation in the levels of pregnancy-specific beta-1-glycoprotein in maternal serum from chromosomally abnormal pregnancies.
Prenatal diagnosis 1992;12(6):505-12.
1991: M Zeitune; David A Aitken; Jennifer A Crossley; J R Yates; A Cooke; Malcolm A Ferguson-Smith
Estimating the risk of a fetal autosomal trisomy at mid-trimester using maternal serum alpha-fetoprotein and age: a retrospective study of 142 pregnancies.
Prenatal diagnosis 1991;11(11):847-57.
1991: Jennifer A Crossley; David A Aitken; J Michael Connor
Prenatal screening for chromosome abnormalities using maternal serum chorionic gonadotrophin, alpha-fetoprotein, and age.
Prenatal diagnosis 1991;11(2):83-101.
1989: M Zeitune; David A Aitken; G W Graham; Jennifer A Crossley; Malcolm A Ferguson-Smith
Amniotic fluid alpha-fetoprotein, gamma-glutamyltranspeptidase, and autosomal trisomies.
Prenatal diagnosis 1989;9(8):559-68.